ScinoPharm Taiwan Ltd
TWSE:1789
ScinoPharm Taiwan Ltd
Gain/Loss on Disposition of Assets
ScinoPharm Taiwan Ltd
Gain/Loss on Disposition of Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gain/Loss on Disposition of Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Gain/Loss on Disposition of Assets
-NT$4.3m
|
CAGR 3-Years
-183%
|
CAGR 5-Years
-150%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Gain/Loss on Disposition of Assets
-NT$821k
|
CAGR 3-Years
14%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Gain/Loss on Disposition of Assets
-NT$655k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Gain/Loss on Disposition of Assets
-NT$47k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
51%
|
CAGR 10-Years
7%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Gain/Loss on Disposition of Assets
-NT$25.4m
|
CAGR 3-Years
-132%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Gain/Loss on Disposition of Assets
-NT$3.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
-12%
|
|
ScinoPharm Taiwan Ltd
Glance View
ScinoPharm Taiwan Ltd. engages in the research, development, manufacturing, and sales of active pharmaceutical ingredients and injections. The company is headquartered in Tainan, Tainan. The company went IPO on 2010-10-29. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The firm is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The firm operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
See Also
What is ScinoPharm Taiwan Ltd's Gain/Loss on Disposition of Assets?
Gain/Loss on Disposition of Assets
-4.3m
TWD
Based on the financial report for Sep 30, 2024, ScinoPharm Taiwan Ltd's Gain/Loss on Disposition of Assets amounts to -4.3m TWD.
What is ScinoPharm Taiwan Ltd's Gain/Loss on Disposition of Assets growth rate?
Gain/Loss on Disposition of Assets CAGR 5Y
-150%
Over the last year, the Gain/Loss on Disposition of Assets growth was -1 132%. The average annual Gain/Loss on Disposition of Assets growth rates for ScinoPharm Taiwan Ltd have been -183% over the past three years , -150% over the past five years .
You don't have any saved screeners yet